Paper19628705
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
Bryceson YT and 2 others. Blood, 2009. Cited by 226 papers, by iCite.
Cite this record
ConductScience Library. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Papers, record 19628705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19628705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Killer Cells, Natural | Major topic |
| Lymphocyte Activation | Major topic |
| Receptors, Natural Cytotoxicity Triggering | Major topic |
| Animals | |
| Antigens, CD | |
| Cell Degranulation | |
| Cells, Cultured | |
| Drosophila | |
| Humans | |
| K562 Cells | |
| Lymphocyte Function-Associated Antigen-1 | |
| NK Cell Lectin-Like Receptor Subfamily D | |
| NK Cell Lectin-Like Receptor Subfamily K | |
| Receptors, Immunologic | |
| Signal Transduction | |
| Signaling Lymphocytic Activation Molecule Family |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| Z01AI000525 | NIH | NIH RePORTER | |||
| ZIAAI000525 | NIH | NIH RePORTER |
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1465448 | Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1465448 | PubMed |
| 2 | 1717493 | Motility and ultrastructure of large granular lymphocytes on lipid bilayers reconstituted with adhesion receptors LFA-1, ICAM-1, and two isoforms of LFA-3. | J Cell Biol | 1991 | https://conductscience.org/library/papers/1717493 | PubMed |
| 3 | 10358164 | CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. | J Immunol | 1999 | https://conductscience.org/library/papers/10358164 | PubMed |
| 4 | 18759921 | Negative signaling by inhibitory receptors: the NK cell paradigm. | Immunol Rev | 2008 | https://conductscience.org/library/papers/18759921 | PubMed |
| 5 | 8574854 | Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. | Immunity | 1996 | https://conductscience.org/library/papers/8574854 | PubMed |
| 6 | 9586352 | Adhesion in NK cell function. | Curr Top Microbiol Immunol | 1998 | https://conductscience.org/library/papers/9586352 | PubMed |
| 7 | 14600256 | T-cell integrins: more than just sticking points. | J Cell Sci | 2003 | https://conductscience.org/library/papers/14600256 | PubMed |
| 8 | 12917349 | Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12917349 | PubMed |
| 9 | 16203869 | Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. | J Exp Med | 2005 | https://conductscience.org/library/papers/16203869 | PubMed |
| 10 | 12740575 | NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12740575 | PubMed |
| 11 | 11753075 | Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. | Curr Opin Hematol | 2002 | https://conductscience.org/library/papers/11753075 | PubMed |
| 12 | 12496412 | Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. | J Immunol | 2003 | https://conductscience.org/library/papers/12496412 | PubMed |
| 13 | 9486650 | HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. | Nature | 1998 | https://conductscience.org/library/papers/9486650 | PubMed |
| 14 | 18394936 | NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. | Immunity | 2008 | https://conductscience.org/library/papers/18394936 | PubMed |
| 15 | 18835194 | Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. | Immunity | 2008 | https://conductscience.org/library/papers/18835194 | PubMed |
| 16 | 19172692 | Formation and function of the lytic NK-cell immunological synapse. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/19172692 | PubMed |
| 17 | 10384100 | Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. | J Immunol | 1999 | https://conductscience.org/library/papers/10384100 | PubMed |
| 18 | 10980383 | Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells. | Hum Immunol | 2000 | https://conductscience.org/library/papers/10980383 | PubMed |
| 19 | 16150947 | Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. | Blood | 2006 | https://conductscience.org/library/papers/16150947 | PubMed |
| 20 | 17624948 | Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. | Immunol Rev | 2007 | https://conductscience.org/library/papers/17624948 | PubMed |
Cited by150
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 226 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42756352 | Research progress on the role and dysregulation of NK cells in anti-tuberculosis immunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42756352 | PubMed |
| 42562863 | Long-term major histocompatibility complex class I suppression in astronauts and clinical implications. | Commun Biol | 2026 | https://conductscience.org/library/papers/42562863 | PubMed |
| 42402596 | From single cell analysis to 3D micro physiological systems: microfluidic tools integrating cancer cell targets for delineating natural killer cell biology. | Microsyst Nanoeng | 2026 | https://conductscience.org/library/papers/42402596 | PubMed |
| 41945756 | HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack. | Blood Adv | 2026 | https://conductscience.org/library/papers/41945756 | PubMed |
| 41656162 | Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41656162 | PubMed |
| 41497321 | Using In silico models to predict lymphocyte activation and development in a data rich era. | Immunoinformatics (Amst) | 2024 | https://conductscience.org/library/papers/41497321 | PubMed |
| 41280875 | Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity. | Theranostics | 2025 | https://conductscience.org/library/papers/41280875 | PubMed |
| 40763024 | Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40763024 | PubMed |
| 40421025 | NKG2D triggering hampers DNAM-1-mediated signaling in human NK cells. | Front Immunol | 2025 | https://conductscience.org/library/papers/40421025 | PubMed |
| 40308580 | ADCC: the rock band led by therapeutic antibodies, tumor and immune cells. | Front Immunol | 2025 | https://conductscience.org/library/papers/40308580 | PubMed |
| 39996727 | In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive Glioblastoma. | Cells | 2025 | https://conductscience.org/library/papers/39996727 | PubMed |
| 39911822 | Natural killer cell engagers for cancer immunotherapy. | Front Oncol | 2024 | https://conductscience.org/library/papers/39911822 | PubMed |
| 39754720 | Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells. | Cell Rep | 2025 | https://conductscience.org/library/papers/39754720 | PubMed |
| 39582357 | Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands. | MAbs | 2024 | https://conductscience.org/library/papers/39582357 | PubMed |
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 39254684 | Enhancing Anti-Cancer Immune Response by Acidosis-Sensitive Nanobody Display. | J Membr Biol | 2024 | https://conductscience.org/library/papers/39254684 | PubMed |
| 39149589 | Authentication and validation of key genes in the treatment of atopic dermatitis with Runfuzhiyang powder: combined RNA-seq, bioinformatics analysis, and experimental research. | Front Genet | 2024 | https://conductscience.org/library/papers/39149589 | PubMed |
| 38993289 | NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors. | Bladder Cancer | 2023 | https://conductscience.org/library/papers/38993289 | PubMed |
| 38619967 | Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | https://conductscience.org/library/papers/38619967 | PubMed |
| 37869010 | Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both? | Front Immunol | 2023 | https://conductscience.org/library/papers/37869010 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ITGAL | 3683 | PubTator's text mining | https://conductscience.org/library/genes/3683 | NCBI Gene |
| KLRC1 | 3821 | PubTator's text mining | https://conductscience.org/library/genes/3821 | NCBI Gene |
| KLRK1 | 22914 | PubTator's text mining | https://conductscience.org/library/genes/22914 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19628705
GET https://conductscience.org/api/papers/v1/19628705/references?page=2